Liabilities of BioLineRx Ltd. from 31 Dec 2016 to 31 Dec 2024

Taxonomy & unit
ifrs-full: USD
Summary
BioLineRx Ltd. quarterly Liabilities in USD history and change rate from 31 Dec 2016 to 31 Dec 2024.
  • BioLineRx Ltd. Liabilities for the quarter ending 31 Dec 2024 was $25,445,000, a 50% decline year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)

BioLineRx Ltd. Quarterly Liabilities (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $25,445,000 -$25,257,000 -50% 31 Dec 2024 20-F 31 Mar 2025 2024 FY
Q2 2024 $50,615,000 +$12,733,000 +34% 30 Jun 2024 6-K 15 Aug 2024 2024 Q2
Q4 2023 $50,702,000 +$25,159,000 +98% 31 Dec 2023 20-F 31 Mar 2025 2024 FY
Q2 2023 $37,882,000 +$26,612,000 +236% 30 Jun 2023 6-K 30 Aug 2023 2023 Q2
Q4 2022 $25,543,000 +$12,239,000 +92% 31 Dec 2022 20-F/A 26 Mar 2024 2023 FY
Q2 2022 $11,270,000 -$6,166,000 -35% 30 Jun 2022 6-K 16 Aug 2022 2022 Q2
Q4 2021 $13,304,000 -$11,956,000 -47% 31 Dec 2021 20-F 22 Mar 2023 2022 FY
Q2 2021 $17,436,000 -$6,323,000 -27% 30 Jun 2021 6-K 18 Aug 2021 2021 Q2
Q4 2020 $25,260,000 +$5,073,000 +25% 31 Dec 2020 20-F 16 Mar 2022 2021 FY
Q2 2020 $23,759,000 +$3,583,000 +18% 30 Jun 2020 6-K 06 Aug 2020 2020 Q2
Q4 2019 $20,187,000 +$5,275,000 +35% 31 Dec 2019 20-F 23 Feb 2021 2020 FY
Q2 2019 $20,176,000 +$14,149,000 +235% 30 Jun 2019 6-K 06 Aug 2019 2019 Q2
Q4 2018 $14,912,000 +$6,828,000 +84% 31 Dec 2018 20-F 12 Mar 2020 2019 FY
Q2 2018 $6,027,000 30 Jun 2018 6-K 13 Aug 2018 2018 Q2
Q4 2017 $8,084,000 +$4,172,000 +107% 31 Dec 2017 20-F 28 Mar 2019 2018 FY
Q4 2016 $3,912,000 31 Dec 2016 20-F 06 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.